Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bronchipret Tropfen
- Development stage
- Unknown
- Lead developer
- Bionorica
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Bronchipret Tropfen is a herbal medicinal product developed by Engelhard Arzneimittel for the treatment of acute bronchitis and respiratory tract infections characterized by cough and mucus production. It is a combination of liquid extracts from thyme (Thymus vulgaris) and ivy (Hedera helix). Thyme possesses secretolytic, bronchospasmolytic, and antibacterial properties, primarily attributed to its essential oil components like thymol and carvacrol. Ivy leaf extract acts as a secretolytic and mucolytic agent, facilitating the expectoration of thick mucus by reducing its viscosity. Together, these ingredients work synergistically to alleviate coughing fits, reduce inflammation in the bronchial tubes, and clear the airways. The formulation is specifically designed as oral drops for efficient dosing and contains approximately 24% ethanol by volume.
- Brand names
- Bronchipret Tropfen
- Other names
- Bronchipret Drops
02
Targets
ADRB2 (β2)ALOX5 (Arachidonate 5-lipoxygenase)
Beyond the preview
Go deeper on Bronchipret Tropfen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bronchipret Tropfen.